Surgery – Means for introducing or removing material from body for... – Material introduced into and removed from body through...
Patent
1996-06-26
1998-09-01
Mendez, Manuel
Surgery
Means for introducing or removing material from body for...
Material introduced into and removed from body through...
A61M 3100
Patent
active
058003851
ABSTRACT:
A method and solution for perioperatively inhibiting a variety of pain, inflammation, spasm and restenosis processes resulting from cardiovascular or general vascular therapeutic and diagnostic procedures. The solution preferably includes multiple pain and inflammation inhibitory agents and spasm inhibitory agents at dilute concentration in a physiologic carrier, such as saline or lactated Ringer's solution. Specific preferred embodiments of the solution of the present invention for use in cardiovascular and general vascular procedures also include anti-restenosis agents. The solution is introduced luminally to continuously irrigate an arterial site during an operative/interventional or diagnostic procedure for preemptive inhibition of pain and inflammation, vascular and non-vascular smooth muscle spasm, and restenosis while avoiding undesirable side effects associated with oral, intramuscular, subcutaneous or intravenous application of larger doses of the agents. One preferred solution to inhibit pain, inflammation, vasospasm and restenosis includes a serotonin.sub.2 antagonist, a cyclooxygenase inhibitor, an endothelin antagonist, an ATP-sensitive K.sup.+ channel antagonist, a Ca.sup.2+ channel antagonist, a nitric oxide donor, an anti-thrombin agent, a glycoprotein IIb/lIIa receptor blocker, a PKC inhibitor and a protein tyrosine kinase inhibitor.
REFERENCES:
patent: 4504493 (1985-03-01), Marshall et al.
patent: 4640912 (1987-02-01), Hausman
patent: 4866088 (1989-09-01), Maurin et al.
patent: 4872865 (1989-10-01), Bloebaum et al.
patent: 4938970 (1990-07-01), Hustead et al.
patent: 5030448 (1991-07-01), Hunter
patent: 5051443 (1991-09-01), Neufeld et al.
patent: 5116615 (1992-05-01), Gokcen et al.
patent: 5228725 (1993-07-01), Witherup et al.
patent: 5250519 (1993-10-01), Conrad et al.
patent: 5272139 (1993-12-01), Cary, Jr.
patent: 5304724 (1994-04-01), Newton
patent: 5350761 (1994-09-01), Van Duzer et al.
patent: 5385889 (1995-01-01), Kyle et al.
patent: 5411743 (1995-05-01), Moore et al.
patent: 5444048 (1995-08-01), Kyle
patent: 5482925 (1996-01-01), Hutsell
patent: 5525357 (1996-06-01), Keefer et al.
patent: 5620687 (1997-04-01), Hart et al.
patent: 5650447 (1997-07-01), Keefer et al.
Klein, J.A., "Anesthesia for Liposuction in Dermatologic Surgery," J. Dermatol. Surg. and Oncol., 14:1124-1132 (1988).
Ostad, A., N. Kageyama, R.L. Moy, "Tumescent Anesthesia with a Lidocaine Dose of 55 mg/kg Is Safe for Liposuction," Dermatol. Surg., 22:921-927 (1996).
Klein, J.A., "Tumescent Technique for Local Anesthesia Improves Safety in Large-Volume Liposuction," Plastic and Reconstr. Surgery, 92(6):1085-1100 (1993).
Klein, J.A., "The Tumescent Technique Anesthesia and Modified Liposuction Technique," Dermatologic Clinics, 8(3):425-437 (1990).
Klein, J.A., "Tumescent Liposuction and Improved Postoperative Care Using Tumescent Liposuction Garments," Dermatologic Clinics, 13(2):329-338 (1995).
El-Sanadiki, M.N., Cross, K.S., Murray, J.J., Schuman, R.W., Mikat, E., McCann, R.L., and Hagen, P.-O., Ann. Surg., "Reduction of Intimal Hyperplasia and Enhanced Reactivity of Experimental Vein Bypass Grafts with Verapamil Treatment," (1990), vol. 212(1):87-96.
Gibbons, G.H. and Dzau, V.J., Science, "Molecular Therapies for Vascular Diseases," (1996), vol. 272:689-693.
Jackson, C.L., bush, R.C., and Bowyer, D.E., Atherosclerosis, "Inhibitory effect of calcium antagonists on balloon catheter-induced arterial smooth muscle cell proliferation and lesion size," (1988), vol. 69:115-122.
Jackson, C.L., Bush, R.C., and Bowyer, D.E., Atherosclerosis, "Mechanism of antiatherogenic action of calcium antagonists," (1989), vol. 80:17-26.
Knorr, A.M., American Journal of Cardiology, "Why is nisoldipine a specific agent in ischemic left ventricular dysfunction?" (1995), vol. 73(13):36E-40E (Abstract only).
Lefkovits, J. and Topol, E.J., Prog. Cardiovasc. Dis., "Pharmacological approaches for the prevention of restenosis after percutaneous coronary intervention," (1997), vol. 40(2):141-58 (Abstract only).
Lloyd-Jones, D.M. and Bloch, K.D., Annual Rev. Med., "The Vascular Biology of Nitric Oxide and its Role in Atherogenesis," (1996), vol. 47:365-75.
Nomoto, A., Hirosumi, J., Sekiguchi, C., Mutoh, S., Yamaguchi, I., and Aoki, H., Atherosclerosis, "Antiatherogenic activity of FR34235 (Nilvadipine), a new potent calcium antagonist," (1987), vol. 64:255-261.
Pierce, P.A. and Peroutka, S.J., Regional Anesthesia, "Dual Effect of the Serotonin Agonist, Sumatriptan, on Peripheral Neurogenic Inflammation," (1996), vol. 21(3):219-225.
West, J.L. and Hubbell, J.A., Proc. Natl. Acad. Sci. USA, "Separation of the arterial wall from blood contact using hydrogel barriers reduces and luminal factors in arterial healing," (1996), vol. 93:13188-13193.
Wheeler, D.B., Randall, A., Sather, W.A., and Tsien, R.W., Progress in Brain Research, "Neuronal calcium channels encoded by the .alpha..sub.1A subunit and their contribution to excitatory synaptic transmission in the CNS," (1995), vol. 105:65-78.
Zochodne, D.W. and Ho L.T., Neurology, "Sumatriptan blocks neurogenic inflammation in the peripheral nerve trunk," (1994), vol. 44:161-163.
Reifart, Nicolaus, M.D., et al., Randomized Comparison of Angioplasty of Complex Coronary Lesions at a Single Center, Circulation, 96(1):91-98 (1997).
Cohen, Barry M. et al., Intracoronary Cocktail Infusion during Rotational Ablation: Safety and Efficacy, Abstract Presented At Transcatheter Cardiovascular Therapeutics, Washington D.C. (1 page), Feb. 22-26, 1995.
Araki, Haruo et al., Longitudinal Propagation of Contradiction in the Isolated Conduit Coronary Arteries of Humans and Pigs, Circulation Research, vol. 64, No. 4, 734-741, 1989.
Willerson, J.T., M.D. et al., Specific Platelet Mediators and Unstable Coronary Artery Lesions, Circulation, 80(1):198-205 (1989).
Ashton, J.H. Ph.D. et al., Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries, Circulation, 73(3):572-578 (1986).
Golino, P., et al., Failure of nitroglycerin and diltiazem to reduce platelet-mediated vasoconstriction in dogs with coronary artery stenosis and endothelial injury: further evidence for thromboxane A2 and serotonin as mediators of coronary artery vasoconstriction in vivo, J. Amer. Coll. Cardio., vol. 15, No. 3, 718-726 (1990).
Golino, P., et al., Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients., New Eng J of Medicine, vol. 324, No. 10, 641-48 (1991).
Golino, P., et al., Local effects of serotonin released during coronary angioplasty, N Eng J Medicine, vol. 330, No. 8, 523-528 (1994).
Yoa, S., et al., Combined ADP and thromboxane A2 antagonism prevents cyclic flow variations in stenosed and endothelium-injured arteries in nonhuman primates, Circulation, 88, 2888-2893 (1993).
Golino, P., et al., Endogenous prostaglandin endoperoxides and prostacyclin modulate and thrombolytic activity of tissue plasminogen activator, J Clin Invest., 86, 1095-1102 (1990).
Ashton, J.H., et al., Serotonin and thromboxane A2-prostaglandin H2 receptor blockade provide protection against epinephrine-induced cyclic flow variations in severely narrowed canine coronary arteries, J Am Cardiol., 13, 755-763 (1989).
Yao, S., et al., Combination of inhibition of thrombin and blockade of thromboxane A2 synthetase and receptors enhances thrombolysis and delays reocclusion in canine coronary arteries, Circulation, 86, 1993-1999 (1992).
J.T. Willerson, et al., Lipsosome-Bound Prostaglandin E.sub.1 Often Prevents Cyclic Flow Variations in Stenosed and Endothelium-Injured Canine Coronary Arteries, Circul. Res 89(4): 1786-1791 (1994).
J.J. Liu, C.I. Johnston & B.F. Buxton, Synergistic Effect of Nisoldipine and Nitroglycerin on Human Internal Mammary Artery, J. Pharmacol. Exp. Therapeutics 268(1): 434-440 (1994).
Cohen, D.J., et al., Intraoperative coronary artery spasm successfully treated with nitroglycerin and nifedipine, Annals of Thor Sur., 36:97-100 (1983).
Podesser, B., et al., Combined perioperative infusion of nifedipine and metop
Demopulos Gregory A.
Herz Jeffrey M.
Pierce Pamela A.
Mendez Manuel
Omeros Medical Systems, Inc.
LandOfFree
Vascular irrigation solution and method for inhibition of pain, does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vascular irrigation solution and method for inhibition of pain, , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vascular irrigation solution and method for inhibition of pain, will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-264331